Phase III under way

Article

New York - Adjuvant therapy with a macrophage-activating growth factor appears to prolong survival in high-risk melanoma, Lynn E. Spitler, M.D., said.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.